Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.740
-0.210 (-5.32%)
Nov 4, 2025, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $201.79 million as of November 4, 2025. Its market cap has decreased by -0.28% in one year.
Market Cap
201.79M
Enterprise Value
184.22M
1-Year Change
-0.28%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $201.79M, an increase of 2.20%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 201.79M | 32.71% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 806.01B |
| Johnson & Johnson | 451.53B |
| AbbVie | 382.71B |
| UnitedHealth Group | 302.80B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Abbott Laboratories | 217.65B |
| Novo Nordisk | 216.34B |